MGB Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$960K Buy
10,046
+277
+3% +$27.2K 0.27% 74
2025
Q3
$952K Sell
9,769
-83
-0.8% -$8.6K 0.27% 76
2025
Q2
$1.05M Sell
9,852
-172
-2% -$17.4K 0.35% 63
2025
Q1
$1M Buy
10,024
+2,951
+42% +$297K 0.36% 72
2024
Q4
$633K Buy
7,073
+262
+4% +$23.1K 0.2% 93
2024
Q3
$569K Buy
6,811
+100
+1% +$7.88K 0.21% 107
2024
Q2
$518K Buy
6,711
+630
+10% +$46.1K 0.19% 112
2024
Q1
$416K Sell
6,081
-750
-11% -$48.2K 0.17% 129
2023
Q4
$395K Buy
+6,831
New +$365K 0.2% 125

Other funds holding BSX

MGB Wealth Management's BSX Position: Q4 2025 in Review

MGB Wealth Management increased its Boston Scientific (BSX) stake by 2.8% in Q4 2025, buying an estimated $27.2K and bringing the position to 10,046 shares worth $960K. The position accounts for 0.27% of the portfolio, ranked #74.

MGB Wealth Management first reported a position in BSX in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.05M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • MGB Wealth Management held 10,046 shares of Boston Scientific worth $960K as of Q4 2025.
  • MGB Wealth Management bought 277 Boston Scientific shares in Q4 2025, an estimated $27.2K.
  • Boston Scientific made up 0.27% of MGB Wealth Management's portfolio in Q4 2025, its #74 holding.
  • MGB Wealth Management first reported a position in Boston Scientific in Q4 2023 and has held it in 9 quarters since.
  • MGB Wealth Management's Boston Scientific position peaked at $1.05M in Q2 2025.
  • 1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on MGB Wealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.